In Anses Opinion dated 19 April 2019, Anses concluded that Epoxiconazole is an endocrine disruptor for humans and non-target organisms. Further to this evaluation, Anses has […]
Following an opinion published on 16/04/2018 by a group of scientists alerting on the risks related to the use of SDHI in agriculture, ANSES organised an […]
As a result of the entry into force of Regulation (EU) 2018/1865 of 28th November 2018 concerning the non-renewal of propiconazole approval, ANSES has withdrawn 23 […]
As a result of the entry into force of Regulation (EU) 2018/1914 of 6th December 2018 concerning the non-renewal of quinoxyfen approval, ANSES has withdrawn 5 […]